Yes, vape temporarily raises blood pressure, primarily through nicotine’s sympathomimetic effects on the cardiovascular system. Within 10-15 minutes of vaping, systolic blood pressure rises by approximately 7-10 mmHg and diastolic by 5-7 mmHg, with heart rate rising 10-15 bpm. The effect typically lasts around 30 minutes per session (mean duration 28 minutes per Journal of Hypertension 2018 study). For frequent vapers throughout the day, blood pressure may be chronically elevated. The British Heart Foundation’s position: nicotine is not a significant health hazard for people without heart conditions, though for those with existing cardiovascular disease, the picture is more concerning.

A 2018 Journal of Hypertension study evaluated 30 mild-to-moderate hypertensive patients (on pharmacological treatment with adequate BP control). E-cigarette vaping was accompanied by significant blood pressure increase lasting around 28 minutes. Compared to placebo (same device, same flavour, no nicotine), EC smoking increased systolic BP by 9.6 ± 4.1 mmHg, diastolic BP by 7.1 ± 3.9 mmHg and heart rate by 16.4 ± 13 bpm. All differences were statistically significant. The American Heart Association has reported similar findings: people who vape had greater increases in blood pressure, heart rate and blood vessel constriction immediately after vaping compared to people who did not use nicotine.

The long-term picture is more nuanced. Most epidemiological studies have not linked chronic nicotine use to sustained higher blood pressure in healthy adults. The BHF position summarises: “Nicotine, while highly addictive, is not a significant health hazard for people without heart conditions. It does not cause acute cardiac events or coronary heart disease, and is not carcinogenic.” However, for UK adults with existing high blood pressure (hypertension), coronary heart disease, heart failure or other cardiovascular conditions, the repeated acute spikes from vape may add to overall cardiovascular load. NHS cardiology guidance for these patients: discuss vape use with your consultant.

How nicotine raises blood pressure mechanistically

Nicotine activates the sympathetic (“fight or flight”) branch of the autonomic nervous system within seconds of inhalation. Specific effects: stimulates the release of catecholamines (adrenaline and noradrenaline) from the adrenal medulla and sympathetic nerve terminals; activates nicotinic acetylcholine receptors at the post-ganglionic sympathetic neurons, increasing sympathetic outflow to the heart and blood vessels; directly stimulates the carotid bodies, increasing sympathetic tone further. The combined effect: heart rate rises, cardiac contractility increases (heart pumps harder), peripheral blood vessels constrict (especially small arterioles), and systemic vascular resistance rises. The blood pressure rise is the mechanical consequence of all these changes. Pod-style devices (like JUUL) deliver nicotine particularly efficiently to the bloodstream, producing larger acute BP spikes than older cig-a-like or open-system vapes. Plasma nicotine levels in vape users can match those in cigarette smokers, which explains why the BP effects are similar in magnitude to smoking.

Why chronic vape may not cause sustained hypertension despite acute spikes

A paradox in the cardiovascular research literature: nicotine causes clear acute BP rises but most chronic smoking studies have not found sustained hypertension in long-term smokers (compared with non-smokers, controlling for other factors). The explanation involves nicotine receptor desensitisation. With chronic exposure, nicotinic acetylcholine receptors become less responsive to each subsequent nicotine dose, dampening the acute BP rise over time. The result: blood pressure may rise acutely with each vape session but the overall daily BP profile in chronic users is not dramatically elevated compared with non-users. However, this paradox does NOT mean vape is risk-free for cardiovascular health. Two cautions: first, the desensitisation reduces but does not eliminate acute spikes, so chronic users still experience multiple daily BP increases. Second, for people with existing cardiovascular disease, these repeated spikes add load to an already compromised system. NHS cardiology pathways for patients with hypertension or heart disease include questions about all nicotine sources, including vape.

Practical guidance for UK vapers with cardiovascular concerns

Five-point framework. First, if you have known hypertension, heart disease or other cardiovascular condition: discuss vape with your GP or cardiologist. The advice will depend on your specific condition and severity. NHS guidance generally favours cessation over continued use of any nicotine product in cardiovascular patients. Second, for healthy adults: the BHF position is that vape is not a significant cardiovascular hazard, though it is not risk-free either. Third, if quitting smoking via vape: the cardiovascular benefit of stopping smoking far outweighs the acute BP effects of vape; vape is much safer than continued smoking for heart health (no CO, no tar, fewer chemicals). Fourth, monitor your own BP if concerned: home BP monitors (£20-£60 at UK pharmacies) allow tracking over weeks. Fifth, plan eventual cessation: BHF and NHS guidance both support eventual cessation of all nicotine products as the ideal endpoint.

For UK vapers concerned about blood pressure, the five-point framework below combines BHF guidance with practical home monitoring advice.

For UK vapers with elevated readings on home monitoring or known hypertension, see your GP. NHS pathways include BP control through lifestyle modification (including reducing or stopping all nicotine), medication if needed, and cardiovascular risk assessment. The BHF position is clear: nicotine is not the primary cardiovascular danger; the combustion products of smoking are. For ex-smokers, vape represents major cardiovascular risk reduction. For never-smokers, vape adds some cardiovascular load without smoking-cessation benefit. Our Omagh and Strabane teams can advise on lower-strength options to reduce acute BP effect if cardiovascular health is a priority.